Rein Therapeutics, Inc. - RNTX
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 12
Latest filed: Jul 21, 2026
| Form | Count |
|---|---|
| 8-K | 4 |
| SCHEDULE 13G/A | 3 |
| SCHEDULE 13G | 3 |
| 4 | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Jul 21, 2026 | 8-K | Jul 20, 2026 | 0001193125-26-310315 | View |
| Jul 14, 2026 | SCHEDULE 13G/A | — | 0002060757-26-000043 | View |
| May 28, 2026 | 4 | May 21, 2026 | 0001193125-26-245832 | View |
| May 13, 2026 | 4 | Apr 30, 2026 | 0001193125-26-220718 | View |
| May 08, 2026 | SCHEDULE 13G/A | — | 0001697316-26-000012 | View |
| May 08, 2026 | SCHEDULE 13G | — | 0001104659-26-057607 | View |
| May 07, 2026 | SCHEDULE 13G | — | 0002073679-26-000049 | View |
| May 06, 2026 | SCHEDULE 13G | — | 0000935836-26-000227 | View |
| May 04, 2026 | 8-K | Apr 30, 2026 | 0001193125-26-204006 | View |
| Mar 02, 2026 | 8-K | Feb 24, 2026 | 0001193125-26-084012 | View |
| Feb 19, 2026 | 8-K | Feb 16, 2026 | 0001193125-26-059545 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | — | 0000921895-26-000365 | View |